{
    "nct_id": "NCT05363267",
    "official_title": "Study of Nutraceutical Intervention With High Phenolic Extra Virgin Olive Oil and Curcumin for Neurofibromatosis, Type 1 (NF1)",
    "inclusion_criteria": "* NF1 diagnosis based on NIH Consensus Conference Criteria and/or genetic testing\n* Measurable cutaneous neurofibromas (cNFs) with or without plexiform NF\n* Aged 18 years or older at the time of written consent\n* Voluntary signed written consent obtained before the performance of any study-related procedure not part of normal medical care\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Concurrent treatment with selumetinib or other MAPK, MEK or mTOR inhibitors, other targeted therapies, chemotherapy or radiation\n* Conditions requiring systemic immunosuppression\n* Swallowing difficulties or strong gag reflex which may interfere with study compliance\n* Any comorbidities that may affect study participation in the judgement of enrolling investigator\n* Psychiatric illness, cognitive challenges, social situations, or other circumstances that would limit compliance with study requirements, per judgment of the enrolling investigator\n* Treatment with high phenolic olive oil or curcumin within six months of study entry\n* Known pregnancy or anticipated conception during the 1 year study period",
    "miscellaneous_criteria": ""
}